Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Carl Zeiss Meditec AG: Correction of a release from 03/06/2019 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
10/10/2019 | 08:55am EST

DGAP Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Correction of a release from 03/06/2019 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

10.10.2019 / 14:53
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: Carl Zeiss Meditec AG
Street: Göschwitzer Str. 51-52
Postal code: 07745
City: Jena, Germany
Germany
Legal Entity Identifier (LEI): 529900GRL4MZ8NMOOK95

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Acquisition and Merger with Oppenheimer Funds Inc. : please see Section 10

3. Details of person subject to the notification obligation
Legal entity: Invesco Ltd.
City of registered office, country: Hamilton, Bermuda

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)

5. Date on which threshold was crossed or reached:
24 May 2019

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 3.57 % 0.00 % 3.57 % 89440570
Previous notification n/a % n/a % n/a % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE0005313704 0 3197302 0.00 % 3.57 %
Total 3197302 3.57 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Invesco Ltd. % % %
Invesco Holding Company Limited % % %
Invesco Holding Company(US), Inc. % % %
Oppenheimer Acquisition Corporation % % %
Oppenheimerfunds, Inc. % % %
OFI Global Asset Management, Inc. % % %
Invesco Group Services, Inc. % % %
Invesco Advisers, Inc. 3.57 % % %
- % % %
Invesco Ltd. % % %
Invesco Holding Company Limited % % %
Invesco Holding Company(US), Inc. % % %
Oppenheimer Acquisition Corporation % % %
Oppenheimerfunds, Inc. % % %
OFI Global Asset Management, Inc. % % %
Invesco Group Services, Inc. % % %
Invesco Capital Management LLC % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
Acquistion and Merger with Oppenheimer Funds Inc. Please see following link for further information: we will add link here post acquisition;https://ir.invesco.com/investor-relations/press-releases/default.aspx?_ga=2.153008441.1018859822.1558359393-832691936.1556037780 

Date
09 Oct 2019



10.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Internet: www.zeiss.de/meditec-ag/ir

 
End of News DGAP News Service

888467  10.10.2019 

fncls.ssp?fn=show_t_gif&application_id=888467&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CARL ZEISS MEDITEC AG
02/19CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
02/17CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
02/10CARL ZEISS MEDITEC : Successful start to fiscal year 2019/20 for Carl Zeiss Medi..
EQ
02/10CARL ZEISS MEDITEC AG : 1st quarter results
CO
02/06CARL ZEISS MEDITEC AG : quaterly earnings release
02/03CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
01/23CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
01/20CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
2019CARL ZEISS MEDITEC : achieves significant increase in sales and earnings in fisc..
PU
2019CARL ZEISS MEDITEC : achieves significant increase in sales and earnings in fisc..
EQ
More news
Financials (EUR)
Sales 2020 1 591 M
EBIT 2020 284 M
Net income 2020 201 M
Finance 2020 577 M
Yield 2020 0,69%
P/E ratio 2020 48,6x
P/E ratio 2021 43,0x
EV / Sales2020 5,84x
EV / Sales2021 5,25x
Capitalization 9 874 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 111,73  €
Last Close Price 110,40  €
Spread / Highest target 26,8%
Spread / Average Target 1,20%
Spread / Lowest Target -46,6%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG-2.20%10 737
THERMO FISHER SCIENTIFIC3.85%136 233
DANAHER CORPORATION6.80%113 999
INTUITIVE SURGICAL, INC.4.01%71 316
BOSTON SCIENTIFIC CORPORATION-4.87%59 962
EDWARDS LIFESCIENCES CORPORATION-1.61%49 079